Eli Lilly and Company | Eli Lilly | North Carolina | state | 2017 | $51,414 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2018 | $171,783 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2017 | $181,044 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2021 | $13,628 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2017 | $29,048 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2020 | $36,097 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2018 | $51,943 | | tax credit/rebate |
Mallinckrodt ARD, Inc. | Mallinckrodt | North Carolina | state | 2017 | $3,047 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2022 | $18,821 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2020 | $27,580 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2021 | $27,752 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2017 | $343,670 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2019 | $385,031 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2018 | $567,686 | | tax credit/rebate |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,537 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $62,249 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2018 | $111,224 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2022 | $19,911 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2021 | $20,214 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2020 | $20,518 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2019 | $20,803 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2018 | $20,975 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2017 | $25,023 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2022 | $53,699 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2021 | $72,208 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2020 | $236,439 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2017 | $305,389 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2018 | $495,412 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2019 | $802,663 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2017 | $14,701 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2020 | $216,022 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2017 | $222,417 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2019 | $536,362 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2020 | $4,380 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2019 | $5,298 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2018 | $15,595 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2017 | $16,654 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2020 | $218,433 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2021 | $512,192 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $1,458,481 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $14,958 | | training reimbursement |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Novartis Gene Therapies (frmly AveXis, Inc.) | Novartis | North Carolina | state | 2022 | $5,798 | | training reimbursement |
Pfizer (project 2) | Pfizer | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Pfizer, Inc. (Chapel Hill) | Pfizer | North Carolina | state | 2022 | $20,984 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2021 | $13,776 | | tax credit/rebate |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2006 | $2,697,365 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2006 | $200,144 | | enterprise zone |
Clay-Park Labs Inc. | Perrigo | New York | state | 2006 | $150,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2007 | $2,870,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2007 | $416,897 | | enterprise zone |
Doral/Pfizer | Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2003 | $343,428 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2003 | $167,430 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $61,743 | | tax credit/rebate; property tax abatement |
Regeneron II(Mill Road) | Regeneron Pharmaceuticals | New York | local | 2003 | $46,350 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $31,580 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2003 | $4,607 | | tax credit/rebate; property tax abatement |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2004 | $3,137,110 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2004 | $1,919,713 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2004 | $355,511 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2004 | $214,683 | | tax credit/rebate; property tax abatement |
Purdue Pharma LP | Purdue Pharma | New York | local | 2004 | $180,174 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2004 | $146,695 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2004 | $85,934 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $68,264 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $34,916 | | tax credit/rebate; property tax abatement |
Valmed Parmaceuticals, Inc. | AbbVie | New York | local | 2004 | $30,430 | | tax credit/rebate; property tax abatement |
Purdue Pharma LP | Purdue Pharma | New York | local | 2004 | $23,560 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2004 | $4,364 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2005 | $3,276,473 | | tax credit/rebate; property tax abatement |
OSI Pharmaceuticals, Inc. | Astellas Pharma | New York | local | 2005 | $1,079,994 | | tax credit/rebate; property tax abatement |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2005 | $701,075 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2005 | $495,039 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2005 | $327,383 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2005 | $258,802 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2005 | $145,551 | | tax credit/rebate; property tax abatement |
Purdue Pharma LP | Purdue Pharma | New York | local | 2005 | $145,481 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2005 | $73,090 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2005 | $56,350 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2005 | $37,383 | | tax credit/rebate; property tax abatement |
IVAX PHARMACEUTICALS | Teva Pharmaceutical Industries | New York | local | 2005 | $5,214 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2005 | $4,276 | | tax credit/rebate; property tax abatement |
Valmed Parmaceuticals, Inc. | AbbVie | New York | local | 2005 | $1,375 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2006 | $3,750,210 | | tax credit/rebate; property tax abatement |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2006 | $2,022,893 | | tax credit/rebate; property tax abatement |
Bausch & Lomb R&D | Bausch Health | New York | local | 2006 | $605,264 | | tax credit/rebate; property tax abatement |
OSI Pharmaceuticals Inc | Astellas Pharma | New York | local | 2006 | $603,892 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2006 | $592,901 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2006 | $266,119 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2006 | $232,682 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $101,286 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $56,648 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2006 | $48,224 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2006 | $42,228 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2006 | $41,965 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $35,965 | | tax credit/rebate; property tax abatement |